Skip to main content

Legend Biotech Corp

LEGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001801198

In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Legend Biotech Corp changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of LEGN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1942200+8
Shares84.3M72.0K86.0M+1.78M (+2.1%)
Value$5.81B$4.97M$5.78B−$32.9M (−0.6%)

2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Legend Biotech Corp at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to LEGN in Q3 2023
InstitutionSharesValue% of portfolio
Iron Triangle Partners LP452,629$30.4M4.44%
Summit Partners Public Asset Management, LLC408,549$27.4M1.73%
Driehaus Capital Management LLC206,103$13.8M0.18%
Two Sigma Advisers, LP100,500$6.75M0.02%
Soros Fund Management LLCSuperinvestorSoros Fund Management90,000$6.05M0.12%
Atika Capital Management LLC68,000$4.57M0.65%
Pictet Asset Management Holding SA67,482$4.53M0.01%
Old Well Partners, LLC45,200$3.04M2.63%
Lighthouse Investment Partners, LLC23,975$1.61M0.10%
Ghost Tree Capital, LLC22,500$1.51M0.73%
BI Asset Management Fondsmaeglerselskab A/S16,710$1.12M0.03%
Schonfeld Strategic Advisors LLC14,500$974.0K0.01%
Vident Advisory, LLC12,270$824.2K0.03%
Graham Capital Management, L.P.10,654$715.6K0.02%
Capstone Investment Advisors, LLC7,262$487.8K0.01%
Oversea-Chinese Banking CORP Ltd7,240$486.1K0.02%
Campbell & CO Investment Adviser LLC7,201$483.7K0.06%
Concentric Capital Strategies, LP7,188$482.8K0.05%
Chicago Partners Investment Group LLC4,935$322.7K0.02%
Walleye Trading LLC2,302$154.6K0.00%
Qube Research & Technologies Ltd2,297$154.3K0.00%
BluePath Capital Management, LLC483$32.4K0.03%
Ronald Blue Trust, Inc.20$1.00K0.00%

Sold out (15)

Institutions that held Legend Biotech Corp at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (2)

Institutions that held Legend Biotech Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LEGN in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Pictet Asset Management SA65,146$4.50M
Efg Capital International Corp.6,834$471.8K